CDC published a new analysis in Morbidity and Mortality Weekly Report (MMWR) that details key clinical considerations for providers prescribing PrEP for adolescents, including the latest safety data on PrEP for adolescents; legal issues about consent for clinical care and confidentiality in their respective states; the therapeutic partnership with adolescents and their parents or guardians; the need to tailor the clinical approach to enhance patient-provider communication; and trends in medication initiation, adherence, and persistence during adolescence.
MMWR: Clinical Considerations for Use of PrEP Among Adolescents
Apr 29, 2020 | Kim Rodgers
About Kim Rodgers
Pronouns: She/Her
Kim Rodgers was formerly the Communications Manager at NACCHO.
Related Posts
- Tools & Resources Communications & Public Relations Public Health and Homelessness
NACCHO Social Media Strategy - National Public Health...
National Public Health Week (NPHW) was from April 1 to April 7, 2024. NACCHO...
Apr 11, 2024 | Emma James